Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster. It was founded in 2019 and is headquartered in Durham, North Carolina.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 13, 2022 | Series A | $19M | 11 | FPV Ventures | — | Detail |
Jul 8, 2021 | Series A | $70M | 10 | Mubadala Capital Ventures | — | Detail |
May 5, 2020 | Seed | — | 3 | Two Sigma Ventures | — | Detail |
Dec 10, 2019 | Seed | $3M | 4 | Felicis Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
FPV Ventures | Yes | Series A |
Alexandria Venture Investments | — | Series A |
Alix Ventures | — | Series A |
Catalio Capital Management | — | Series A |
Duke Angel Network | — | Series A |
EQT AB | — | Series A |
Felicis Ventures | — | Series A |
GV | — | Series A |
Mubadala Capital Ventures | — | Series A |
Pear VC | — | Series A |